the lowest Atenolol and Scopolamine Dosage Form: tablet Print this page Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Take one tablet orally as directed by your physician as needed for symptoms of panic or anxiety. Do not exceed two tablets per day. TPS LLC 3524 DECATUR HWY FULTONDALE, AL 35068 877-608-4995 1-877-608-4995 BT9752747 Caution: Federal law prohibits transfer of this drug to any other person than patient for whom prescribed Rx 263095 Jack Doe/Dr. Jane Doe MD JOHN DOE 123 MAIN ST AUBURN, AL 12345 ATENOLOL SCOPOLAMINE TABLET TRITURATE 50 MG/0.5 MG 48 TABS Lot# Exp Take 1 tablet sublingually or orally as directed by your physician as needed for symptoms of panic or anxiety. Do not exceed 2 tablets per day PH No refills authorized 10/8/2014 Pill bottle low res.jpg ATENOLOL SCOPOLAMINE atenolol scopolamine tablet Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:69267-102 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATENOLOL (ATENOLOL) ATENOLOL 50 mg in 50.5 mg SCOPOLAMINE HYDROBROMIDE (SCOPOLAMINE) SCOPOLAMINE HYDROBROMIDE .5 mg in 50.5 mg Product Characteristics Color white Score no score Shape ROUND (THE DIAMETER DEPENDS ON DIES) Size 5mm Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:69267-102-06 303 mg in 1 BOTTLE, PLASTIC 2 NDC:69267-102-12 606 mg in 1 BOTTLE, PLASTIC 3 NDC:69267-102-24 1212 mg in 1 BOTTLE, PLASTIC 4 NDC:69267-102-48 2424 mg in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 10/01/2014 Labeler - TPS (044805267) Establishment Name Address ID/FEI Operations TPS 044805267 manufacture(69267-102) Revised: 10/2014 TPS FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Recently Approved Lonhala Magnair Lonhala Magnair (glycopyrrolate) is a long-acting muscarinic antagonist (LAMA) bronchodilator for... Ozempic Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog administered once-weekly for the... Ogivri Ogivri (trastuzumab-dkst) is a HER2 / neu receptor antagonist biosimilar to Herceptin indicated for... Sublocade Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the... More adjustments
advised Atenolol and Scopolamine wonderful
EmoticonEmoticon